(Q34903518)

5 August 2017

1 reference

title

Inclusion body myositis: review of recent literature (English)

1 reference

5 August 2017

main subject

inclusion body myositis

1 reference

Steven A Greenberg

1

1 reference

5 August 2017

publication date

1 January 2009

1 reference

Current Neurology and Neuroscience Reports

5 August 2017

published in

1 reference

5 August 2017

volume

9

1 reference

5 August 2017

issue

1

1 reference

5 August 2017

page(s)

83-89

1 reference

https://scigraph.springernature.com/pub.10.1007/s11910-009-0013-x

5 August 2017

exact match

0 references

cites work

Epidemiology of inclusion body myositis in the Netherlands: a nationwide study.

1 reference

https://api.crossref.org/works/10.1007%2FS11910-009-0013-X

Molecular profiles of inflammatory myopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-009-0013-X

A local antigen-driven humoral response is present in the inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-009-0013-X

Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-009-0013-X

Transgenic mice over-expressing the C-99 fragment of betaPP with an alpha-secretase site mutation develop a myopathy similar to human inclusion body myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-009-0013-X

Rabbits fed cholesterol-enriched diets exhibit pathological features of inclusion body myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-009-0013-X

Myxovirus-like structures and accompanying nuclear changes in chronic polymyositis

21 January 2018

1 reference

12 December 2020

Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM

1 reference

12 December 2020

Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases

1 reference

12 December 2020

Pathogenic accumulation of APP in fast twitch muscle of IBM patients and a transgenic model

1 reference

12 December 2020

The ER-bound RING finger protein 5 (RNF5/RMA1) causes degenerative myopathy in transgenic mice and is deregulated in inclusion body myositis

1 reference

12 December 2020

Sporadic inclusion body myositis correlates with increased expression and cross-linking by transglutaminases 1 and 2

1 reference

12 December 2020

Inclusion-body myositis, a multifactorial muscle disease associated with aging: current concepts of pathogenesis

1 reference

12 December 2020

Myeloid dendritic cells in inclusion-body myositis and polymyositis.

1 reference

12 December 2020

Conspicuous accumulation of a single-stranded DNA binding protein in skeletal muscle fibers in inclusion body myositis

1 reference

12 December 2020

119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands

1 reference

12 December 2020

Sporadic inclusion body myositis: a continuing puzzle

1 reference

12 December 2020

A gene expression approach to study perturbed pathways in myositis

1 reference

12 December 2020

Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition

1 reference

12 December 2020

Inclusion body myositis and myopathies

1 reference

12 December 2020

NOGO is increased and binds to BACE1 in sporadic inclusion-body myositis and in A beta PP-overexpressing cultured human muscle fibers.

1 reference

12 December 2020

Further observations on forearm flexor weakness in inclusion body myositis

1 reference

12 December 2020

Plasma cells in muscle in inclusion body myositis and polymyositis.

1 reference

12 December 2020

Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol

1 reference

12 December 2020

Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications

1 reference

12 December 2020

Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis.

1 reference

12 December 2020

Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches

1 reference

12 December 2020

Nuclear membrane proteins are present within rimmed vacuoles in inclusion-body myositis.

1 reference

12 December 2020

Casein kinase 1 alpha associates with the tau-bearing lesions of inclusion body myositis

1 reference

12 December 2020

beta-Amyloid precursor epitopes in muscle fibers of inclusion body myositis

1 reference

12 December 2020

Expression of beta-amyloid precursor protein gene is developmentally regulated in human muscle fibers in vivo and in vitro

1 reference

12 December 2020

Nuclear localization of valosin-containing protein in normal muscle and muscle affected by inclusion-body myositis

1 reference

12 December 2020

Ubiquitin and beta-amyloid-protein in inclusion body myositis (IBM), familial IBM-like disorder and oculopharyngeal muscular dystrophy: an immunocytochemical study

1 reference

12 December 2020

Increase in transglutaminase 2 in idiopathic inflammatory myopathies

1 reference

12 December 2020

Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle

1 reference

12 December 2020

Genetically augmenting Abeta42 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice

1 reference

12 December 2020

Transgenic mice expressing the human C99 terminal fragment of betaAPP: effects on cytochrome oxidase activity in skeletal muscle and brain.

1 reference

12 December 2020

Interplay between inflammation and degeneration: using inclusion body myositis to study "neuroinflammation"

1 reference

12 December 2020

Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3beta

1 reference

12 December 2020

Ubiquitinated inclusions in inclusion-body myositis patients are immunoreactive for cathepsin D but not beta-amyloid

1 reference

12 December 2020

Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis.

1 reference

12 December 2020

Muscular dystrophy in adult and aged anti-NGF transgenic mice resembles an inclusion body myopathy

1 reference

12 December 2020

Two-dimensional gel electrophoresis in inclusion body myositis

1 reference

12 December 2020

Synaptic dysfunction does not contribute to muscle weakness in inclusion-body myositis

1 reference

12 December 2020

Upregulation of thrombospondin-1(TSP-1) and its binding partners, CD36 and CD47, in sporadic inclusion body myositis.

1 reference

12 December 2020

Amyloid beta-peptide is produced by cultured cells during normal metabolism

1 reference

12 December 2020

Inclusion body myositis functional rating scale: A reliable and valid measure of disease severity

1 reference

12 December 2020

beta-Amyloid precursor protein mRNA is increased in inclusion-body myositis muscle.

1 reference

12 December 2020

Comment on 'Interrelation of inflammation and APP in sIBM: IL-1beta induces accumulation of beta-amyloid in skeletal muscle'.

1 reference

12 December 2020

Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies

1 reference

12 December 2020

T cell receptor profiling in muscle and blood lymphocytes in sporadic inclusion body myositis

1 reference

12 December 2020

Myxovirus-Like Structures in a Case of Human Chronic Polymyositis

1 reference

12 December 2020

In inclusion-body myositis muscle fibers Parkinson-associated DJ-1 is increased and oxidized

1 reference

12 December 2020

Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota

1 reference

12 December 2020

Serial quantitative electrophysiologic studies in sporadic inclusion body myositis.

1 reference

12 December 2020

Molecular immunology and genetics of inflammatory muscle diseases

1 reference

12 December 2020

Single-fiber electromyography in sporadic inclusion body myopathy

1 reference

12 December 2020

Inclusion body myositis: clinical and pathological boundaries.

1 reference

12 December 2020

Apolipoprotein epsilon alleles in sporadic inclusion body myositis: a reappraisal

1 reference

12 December 2020

Treatment of inclusion body myositis with cyclosporin-A or tacrolimus: successful long-term management in patients with earlier active disease and concomitant autoimmune features

1 reference

12 December 2020

Histone H1 is released from myonuclei and present in rimmed vacuoles with DNA in inclusion body myositis

1 reference

12 December 2020

Transgenic expression of beta-APP in fast-twitch skeletal muscle leads to calcium dyshomeostasis and IBM-like pathology

1 reference

12 December 2020

Human muscle macrophages express beta-amyloid precursor and prion proteins and their mRNAs.

1 reference

12 December 2020

Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle

1 reference

12 December 2020

Chemokine profile of different inflammatory myopathies reflects humoral versus cytotoxic immune responses.

1 reference

12 December 2020

Inclusion body myositis

1 reference

12 December 2020

10.1007/S11910-009-0013-X

Identifiers

DOI

1 reference

Dimensions Publication ID

5 August 2017

1029365630

0 references

1 reference